Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
0.1150
+0.0020 (1.77%)
Aug 27, 2026, 2:33 PM HKT
HKG:8329 Market Cap
HKG:8329 has a market cap or net worth of 189.61 million as of August 27, 2026. Its market cap has decreased by -28.03% in one year.
Market Cap
189.61M
Enterprise Value
119.68M
Revenue
1.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since September 12, 2005, HKG:8329's market cap has decreased from 345.53M to 189.61M, a decrease of -45.12%. That is a compound annual growth rate of -2.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 189.61M | -28.93% |
| Dec 31, 2025 | 266.80M | -2.45% |
| Dec 31, 2024 | 273.51M | -0.61% |
| Dec 29, 2023 | 275.19M | -4.65% |
| Dec 30, 2022 | 288.62M | -7.03% |
| Dec 31, 2021 | 310.43M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 668.33M |
| Zhongzhi Pharmaceutical Holdings | 591.57M |
| China NT Pharma Group Company | 398.58M |
| Wai Yuen Tong Medicine Holdings | 323.17M |
| Regent Pacific Group | 259.72M |
| Tianda Pharmaceuticals | 240.80M |
| Extrawell Pharmaceutical Holdings | 226.20M |
| Kontafarma China Holdings | 167.66M |